BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15183844)

  • 21. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif.
    Makkar P; Metpally RP; Sangadala S; Reddy BV
    J Mol Graph Model; 2009 Apr; 27(7):803-12. PubMed ID: 19157940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
    Seo T; Park J; Choe J
    Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
    Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
    Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.
    Osawa H; Nakajima M; Kato H; Fukuchi M; Kuwano H
    Anticancer Res; 2004; 24(6):3703-9. PubMed ID: 15736400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.
    Koinuma D; Tsutsumi S; Kamimura N; Taniguchi H; Miyazawa K; Sunamura M; Imamura T; Miyazono K; Aburatani H
    Mol Cell Biol; 2009 Jan; 29(1):172-86. PubMed ID: 18955504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
    Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
    Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta.
    von Gersdorff G; Susztak K; Rezvani F; Bitzer M; Liang D; Böttinger EP
    J Biol Chem; 2000 Apr; 275(15):11320-6. PubMed ID: 10753944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression.
    Jinnin M; Ihn H; Tamaki K
    Mol Pharmacol; 2006 Feb; 69(2):597-607. PubMed ID: 16288083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.
    Weng H; Mertens PR; Gressner AM; Dooley S
    J Hepatol; 2007 Feb; 46(2):295-303. PubMed ID: 17125875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.
    Ohsawa Y; Hagiwara H; Nakatani M; Yasue A; Moriyama K; Murakami T; Tsuchida K; Noji S; Sunada Y
    J Clin Invest; 2006 Nov; 116(11):2924-34. PubMed ID: 17039257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney.
    Banas MC; Parks WT; Hudkins KL; Banas B; Holdren M; Iyoda M; Wietecha TA; Kowalewska J; Liu G; Alpers CE
    J Histochem Cytochem; 2007 Mar; 55(3):275-85. PubMed ID: 17142805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for TGF-beta1 and bleomycin intracellular signaling through autocrine regulation of Smad 3 binding to the proximal promoter of the Smad 7 gene.
    Cutroneo KR
    J Cell Biochem; 2006 Apr; 97(5):933-9. PubMed ID: 16187293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
    He WX; Niu ZY; Zhao SL; Smith AJ
    Arch Oral Biol; 2005 Nov; 50(11):929-36. PubMed ID: 16183370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation.
    Stopa M; Anhuf D; Terstegen L; Gatsios P; Gressner AM; Dooley S
    J Biol Chem; 2000 Sep; 275(38):29308-17. PubMed ID: 10887185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulated TGF-beta1-induced Smad signalling occurs as a result of defects in multiple components of the TGF-beta signalling pathway in human head and neck carcinoma cell lines.
    Pring M; Prime S; Parkinson EK; Paterson I
    Int J Oncol; 2006 May; 28(5):1279-85. PubMed ID: 16596245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
    Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
    Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.